Zetia and Exercise: What You Need to Know About Ezetimibe During Daily Activity

How ezetimibe works

Ezetimibe blocks the sterol transporter NPC1L1 at the brush border of the small intestine, which reduces cholesterol delivery to the liver and increases LDL receptor clearance of LDL from the blood [1].

Muscle symptoms: what the label reports

The Warnings and Precautions section says Zetia may cause myopathy, described as muscle pain, tenderness or weakness with elevated creatine kinase, and rhabdomyolysis. In postmarketing reports, most patients who developed rhabdomyolysis were taking a statin or another agent known to raise that risk, such as a fibrate. The label says that if myopathy is suspected, ezetimibe and other concomitant medicines should be discontinued as appropriate [1].

Trial rates give a sense of scale. In 10 placebo-controlled monotherapy trials (2,396 people on ezetimibe 10 mg vs 1,159 on placebo, median 12 weeks), arthralgia was reported in 3.0% vs 2.2% and pain in extremity in 2.7% vs 2.5% [1]. In the statin combination trials (11,308 on ezetimibe plus a statin vs 9,361 on a statin alone), myalgia was 3.2% vs 2.7% [1].

In IMPROVE-IT, 18,144 people hospitalized for acute coronary syndrome were assigned to simvastatin 40 mg plus ezetimibe 10 mg or simvastatin 40 mg plus placebo, with median follow-up of 6 years. Muscle, gallbladder and hepatic adverse effects and cancer were similar between the groups [2]. That trial tested the two-drug combination, and the Zetia label itself carries no cardiovascular outcomes claim [1].

Exercise alongside ezetimibe

A review of best medical treatment for carotid artery stenosis lists moderate exercise among lifestyle measures and lipid-lowering with statins or ezetimibe among the pharmacological components [3]. For symptomatic intracranial atherosclerotic stenosis, a review describes ezetimibe as beneficial for people who do not reach LDL targets or who cannot take a statin, with a treatment target below 70 mg/dL. It also encourages some physical activity in everyone not severely disabled: a minimum of 10 minutes of moderate-intensity aerobic activity four times a week for those able to exercise [4].

Timing the dose around a workout

The dose is 10 mg once daily with or without food, and food does not change the extent of absorption; a high-fat meal raised peak ezetimibe concentration by 38% [1]. Half-life is about 22 hours [1]. The label's spacing instruction concerns bile acid sequestrants such as cholestyramine, where ezetimibe is taken at least 2 hours before or 4 hours after [1]. The label says a missed dose should be taken as soon as possible and the next dose should not be doubled [1].

Liver enzymes

The label also warns about liver enzyme abnormalities. In controlled studies where ezetimibe and a statin were started together, consecutive rises in ALT or AST of 3 times the upper limit of normal or more occurred in 1.3% with the combination vs 0.4% with the statin alone. The label calls for liver enzyme testing as clinically indicated and consideration of withdrawal if such a rise persists [1].

This page describes the single-ingredient Zetia label. Ezetimibe/simvastatin (Vytorin), rosuvastatin/ezetimibe and bempedoic acid/ezetimibe (Nexlizet) are separate products with their own labels and warnings.